A clinician-grade review of dulaglutide (Trulicity) pharmacokinetics covering absorption, distribution, metabolism, and elimination, with FDA and PubMed-cited evidence.
Why dulaglutide (Trulicity) stops working and what to do about it. MD-level plateau troubleshooting covering dose optimization, GLP-1 receptor tachyphylaxis, combination strategies, and switch protocols backed by primary trial data.
Evidence-based guidance on how long to hold dulaglutide (Trulicity) before surgery, why delayed gastric emptying raises aspiration risk, and how to manage blood glucose in the perioperative period.
Stopping dulaglutide (Trulicity) can trigger glycemic rebound, weight regain, and loss of cardiovascular protection. Learn what the clinical evidence supports, what remains unverified, and how to plan a discontinuation with your care team.
A physician-level review of dulaglutide's effects on kidney function, including REWIND trial data, GFR trajectories, albuminuria outcomes, and clinical guidance for patients with CKD.
When and how to safely restart dulaglutide (Trulicity) after acute illness, hospitalization, or GI upset. Evidence-based dosing protocols, monitoring parameters, and red flags from the REWIND trial and ADA guidelines.
A clinical guide to dulaglutide (Trulicity) seasonal use considerations, covering heat stability, cold-weather injection technique, holiday eating patterns, illness management, and cardiovascular evidence from REWIND.
A careful look at how dulaglutide (Trulicity) plausibly affects sleep, including GLP-1 receptor biology, nausea-related sleep disruption during titration, and the indirect route from weight loss to obstructive sleep apnea improvement. Notes where dedicated polysomnography evidence does not exist.
Evidence-based guide to storing Trulicity (dulaglutide) pens correctly, including refrigeration requirements, room-temperature windows, shelf life data, and what to do if a pen is left out.
A clinician-level guide to switching between dulaglutide (Trulicity) and other GLP-1 receptor agonists, covering dose conversion, washout timing, cardiovascular evidence from REWIND, and practical injection guidance.
A guide to discontinuing Trulicity (dulaglutide), covering tapering strategies, rebound hyperglycemia risk, medication transitions, and what to monitor after your last dose.
A week-by-week guide to dulaglutide (Trulicity) in your first month: side effects, blood sugar changes, dosing milestones, and what the evidence from REWIND and AWARD trials actually shows.